32522287|t|A GM-CSF-neuroantigen tolerogenic vaccine elicits inefficient antigen recognition events below the CD40L triggering threshold to expand CD4+ CD25+ FOXP3+ Tregs that inhibit experimental autoimmune encephalomyelitis (EAE).
32522287|a|BACKGROUND: Tolerogenic vaccines represent antigen-specific interventions designed to re-establish self-tolerance and thereby alleviate autoimmune diseases, which collectively comprise over 100 chronic inflammatory diseases afflicting more than 20 million Americans. Tolerogenic vaccines comprised of single-chain GM-CSF-neuroantigen (GMCSF-NAg) fusion proteins were shown in previous studies to prevent and reverse disease in multiple rodent models of experimental autoimmune encephalomyelitis (EAE) by a mechanism contingent upon the function of CD4+ CD25+ FOXP3+ regulatory T cells (Tregs). GMCSF-NAg vaccines inhibited EAE in both quiescent and inflammatory environments in association with low-efficiency T cell receptor (TCR) signaling events that elicited clonal expansion of immunosuppressive Tregs. METHODS: This study focused on two vaccines, including GMCSF-MOG (myelin oligodendrocyte glycoprotein 35-55/MOG35-55) and GMCSF-NFM (neurofilament medium peptide 13-37/NFM13-37), that engaged the transgenic 2D2 TCR with either low or high efficiencies, respectively. 2D2 mice were crossed with FOXP3 IRES eGFP (FIG) mice to track Tregs and further crossed with Rag-/- mice to reduce pre-existing Treg populations. RESULTS: This study provided evidence that low and high efficiency TCR interactions were integrated via CD40L expression levels to control the Treg/Tcon balance. The high-efficiency GMCSF-NFM vaccine elicited memory Tcon responses in association with activation of the CD40L costimulatory system. Conversely, the low-efficiency GMCSF-MOG vaccine lacked adequate TCR signal strength to elicit CD40L expression and instead elicited Tregs by a mechanism that was impaired by a CD40 agonist. When combined, the low- and high-efficiency GMCSF-NAg vaccines resulted in a balanced outcome and elicited both Tregs and Tcon responses without the predominance of a dominant immunogenic Tcon response. Aside from Treg expansion in 2D2-FIG mice, GMCSF-MOG caused a sustained decrease in TCR-beta, CD3, and CD62L expression and a sustained increase in CD44 expression in Tcon subsets. Subcutaneous administration of GMCSF-MOG without adjuvants inhibited EAE in wildtype mice, which had a replete Treg repertoire, but was pathogenic rather than tolerogenic in 2D2-FIG-Rag1-/- mice, which lacked pre-existing Tregs. CONCLUSIONS: This study provided evidence that the GMCSF-MOG vaccine elicited antigenic responses beneath the CD40L triggering threshold, which defined an antigenic niche that drove dominant expansion of tolerogenic myelin-specific Tregs that inhibited EAE.
32522287	2	8	GM-CSF	Gene	12981
32522287	99	104	CD40L	Gene	21947
32522287	136	139	CD4	Gene	12504
32522287	141	145	CD25	Gene	16184
32522287	147	152	FOXP3	Gene	20371
32522287	173	214	experimental autoimmune encephalomyelitis	Disease	MESH:D004681
32522287	216	219	EAE	Disease	MESH:D004681
32522287	358	377	autoimmune diseases	Disease	MESH:D001327
32522287	424	445	inflammatory diseases	Disease	MESH:D007249
32522287	536	542	GM-CSF	Gene	12981
32522287	557	563	GMCSF-	Gene	12981
32522287	563	566	NAg	Gene	71169
32522287	675	716	experimental autoimmune encephalomyelitis	Disease	MESH:D004681
32522287	718	721	EAE	Disease	MESH:D004681
32522287	770	773	CD4	Gene	12504
32522287	775	779	CD25	Gene	16184
32522287	781	786	FOXP3	Gene	20371
32522287	816	821	GMCSF	Gene	12981
32522287	822	825	NAg	Gene	71169
32522287	845	848	EAE	Disease	MESH:D004681
32522287	871	883	inflammatory	Disease	MESH:D007249
32522287	932	947	T cell receptor	Gene	328483
32522287	949	952	TCR	Gene	328483
32522287	1085	1090	GMCSF	Gene	12981
32522287	1091	1094	MOG	Gene	17441
32522287	1152	1157	GMCSF	Gene	12981
32522287	1158	1161	NFM	Gene	18040
32522287	1241	1244	TCR	Gene	328483
32522287	1301	1305	mice	Species	10090
32522287	1324	1329	FOXP3	Gene	20371
32522287	1346	1350	mice	Species	10090
32522287	1398	1402	mice	Species	10090
32522287	1511	1514	TCR	Gene	328483
32522287	1548	1553	CD40L	Gene	21947
32522287	1626	1631	GMCSF	Gene	12981
32522287	1632	1635	NFM	Gene	18040
32522287	1713	1718	CD40L	Gene	21947
32522287	1778	1781	MOG	Gene	17441
32522287	1806	1809	TCR	Gene	328483
32522287	1836	1841	CD40L	Gene	21947
32522287	1918	1922	CD40	Gene	21939
32522287	1976	1981	GMCSF	Gene	12981
32522287	1982	1985	NAg	Gene	71169
32522287	2172	2176	mice	Species	10090
32522287	2184	2187	MOG	Gene	17441
32522287	2219	2227	TCR-beta	Gene	21577
32522287	2229	2232	CD3	Gene	12503
32522287	2238	2243	CD62L	Gene	20343
32522287	2283	2287	CD44	Gene	12505
32522287	2353	2356	MOG	Gene	17441
32522287	2385	2388	EAE	Disease	MESH:D004681
32522287	2401	2405	mice	Species	10090
32522287	2498	2502	Rag1	Gene	19373
32522287	2506	2510	mice	Species	10090
32522287	2602	2605	MOG	Gene	17441
32522287	2655	2660	CD40L	Gene	21947
32522287	2798	2801	EAE	Disease	MESH:D004681
32522287	Positive_Correlation	12981	16184
32522287	Bind	12981	71169
32522287	Association	MESH:D004681	20371
32522287	Association	MESH:D004681	16184
32522287	Association	MESH:D004681	12504
32522287	Association	12504	21947
32522287	Negative_Correlation	17441	21577
32522287	Positive_Correlation	12981	20371
32522287	Positive_Correlation	12504	12981
32522287	Positive_Correlation	12981	21947
32522287	Negative_Correlation	12981	17441
32522287	Negative_Correlation	12503	17441
32522287	Negative_Correlation	MESH:D004681	12981
32522287	Positive_Correlation	17441	21947
32522287	Association	MESH:D004681	328483
32522287	Positive_Correlation	18040	21947
32522287	Association	20371	21947
32522287	Association	16184	21947
32522287	Positive_Correlation	17441	21939
32522287	Negative_Correlation	17441	20343
32522287	Positive_Correlation	12981	328483
32522287	Positive_Correlation	12505	17441
32522287	Association	12981	18040
32522287	Association	21947	328483
32522287	Positive_Correlation	18040	328483
32522287	Association	328483	71169
32522287	Negative_Correlation	MESH:D004681	71169
32522287	Association	MESH:D004681	21947

